IGC Pharma, Inc.
IGC
$0.29
$0.000.32%
AMEX
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -6.45M | -6.34M | -7.12M |
| Total Depreciation and Amortization | -- | -- | 571.00K | 597.00K | 618.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1.09M | 1.81M | 1.78M |
| Change in Net Operating Assets | -- | -- | -761.00K | -510.00K | -72.00K |
| Cash from Operations | -- | -- | -5.54M | -4.45M | -4.80M |
| Capital Expenditure | -- | -- | -82.00K | -82.00K | -112.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 703.00K | 742.00K | 40.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -661.00K | -391.00K | -370.00K |
| Cash from Investing | -- | -- | -40.00K | 269.00K | -442.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -3.00K | -3.00K | -3.00K |
| Issuance of Common Stock | -- | -- | 5.11M | 2.80M | 4.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 5.11M | 2.80M | 4.45M |
| Foreign Exchange rate Adjustments | -- | -- | 32.00K | 16.00K | -7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -441.00K | -1.37M | -793.00K |